Reduced microperfusion due to portal vein thrombosis: Impact on the outcome of percutaneous thermal tumor ablation

Pregler, B. and Beyer, L. P. and Wiesinger, I. and Haimerl, M. and Stroszczynski, C. and Jung, E. M. and Wiggermann, P. (2017) Reduced microperfusion due to portal vein thrombosis: Impact on the outcome of percutaneous thermal tumor ablation. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 67 (3-4). pp. 383-388. ISSN 1386-0291, 1875-8622

Full text not available from this repository. (Request a copy)

Abstract

PURPOSE: To determine the influence of pre-interventionally existing portal vein thrombosis on the ablation success of percutaneous tumor ablation of HCC. MATERIALS AND METHODS: 15 patients with HCC and pre-existing portal vein thrombosis underwent thermal tumor ablation. We retrospectively analyzed the pre- and post-interventionally performed CT and MRI scans in terms of technical success as well as the complication rate. The portal vein thrombosis was classified into segmental, lobar and central thrombus. RESULTS: In 13/15 cases (87%) complete ablation with no evidence of residual tumor tissue was seen 6 weeks after the procedure in contrast-enhanced MRI scans and contrast-enhanced ultrasound (CEUS). No major and 2 minor complications were observed after the ablation procedure. CONCLUSION: Reduced perfusion due to pre-interventionally existing portal vein thrombosis has no significant impact on the ablation success or the complication rate.

Item Type: Article
Uncontrolled Keywords: HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; LIVER-TUMORS; SAFETY; COMPLICATIONS; EFFICACY; HCC; portal vein thrombosis; ablation; RFA; MWA
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Röntgendiagnostik
Depositing User: Dr. Gernot Deinzer
Date Deposited: 14 Dec 2018 13:01
Last Modified: 26 Apr 2019 11:56
URI: https://pred.uni-regensburg.de/id/eprint/600

Actions (login required)

View Item View Item